Drug class

Antidepressants Alpha-2 Receptor Antagonists

Alpha-2 receptor antagonist antidepressants, also commonly referred to in clinical literature as noradrenergic and specific serotonergic antidepressants (NaSSAs) or tetracyclic antidepressants like mirtazapine, are psychotropic agents used primarily in psychiatry. Read more about Antidepressants Alpha-2 Receptor Antagonists

28 drugs in this class 25 manufacturers

Advertisement

Drugs in Antidepressants Alpha-2 Receptor Antagonists

Showing 1–9 of 28 drugs

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
Mylan Pharmaceuticals

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
AHP

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
APOTEX CORP

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
AUROBINDO PHARM

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
AUROBINDO PHARM

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
Major Pharamceuticals

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
SUN PHARMACEUTI

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
NORTHSTAR RX LL

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
RISING PHARM
Filter & compare in the drug finder → Opens the drug finder with Antidepressants Alpha-2 Receptor Antagonists preselected. Add indication or manufacturer filters there.

About Antidepressants Alpha-2 Receptor Antagonists.

Alpha-2 receptor antagonist antidepressants, also commonly referred to in clinical literature as noradrenergic and specific serotonergic antidepressants (NaSSAs) or tetracyclic antidepressants like mirtazapine, are psychotropic agents used primarily in psychiatry.

Their principal mechanism involves blocking central presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, thereby interrupting negative feedback loops and enhancing the synaptic release of both norepinephrine and serotonin.

They frequently display concurrent antagonist actions at postsynaptic serotonin 5-HT2 and 5-HT3 receptors, as well as histamine H1 receptors, contributing to sedative and appetite-stimulating effects.

Clinically, these agents are primarily indicated for major depressive disorder and are routinely used to manage depression characterized by insomnia, weight loss, or comorbid anxiety symptoms.